personalized medicine

Research in Review
Immunotherapy Better Than Standard of Care for Type of DLBCL
08/03/2017
JCP Editors
Single-agent immunotherapy in patients with a subtype of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) provides more clinical benefit than conventional therapy, according to research published in...
Single-agent immunotherapy in patients with a subtype of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) provides more clinical benefit than conventional therapy, according to research published in...
...
08/03/2017
Journal of Clinical Pathways
Research in Review
Novel Ovarian Cancer Subtypes Associated With Survival Outcomes Following Surgery
08/02/2017
JCP Editors
High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...
High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...
...
08/02/2017
Journal of Clinical Pathways
Research in Review
Cancer Symptoms More Important Than Diagnosis for Palliative Care
07/27/2017
JCP Editors
Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...
Results of a recent survey showed that for patients with cancer requiring palliative care, some symptoms and care needs are not strongly associated with specific diagnoses, published in Supportive Care in Cancer...
...
07/27/2017
Journal of Clinical Pathways
Research in Review
NSCLC Prognostic Index Considers Personal Characteristics to Better Predict Outcomes
07/26/2017
JCP Editors
The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...
The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...
The...
07/26/2017
Journal of Clinical Pathways
Research in Review
Novel Prognostic Index Designed for Patients With MZL
07/19/2017
JCP Editors
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new...
07/19/2017
Journal of Clinical Pathways
Research in Review
Model Predicts Tumor Spread in Lung Cancer
07/17/2017
JCP Editors
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...
...
07/17/2017
Journal of Clinical Pathways
Research in Review
PD-L2 Expression May Indicate Response to Immunotherapy in Head and Neck Cancer
06/15/2017
JCP Editors
A recent study suggests that immunotherapies targeting both PD-L1 and PD-L2 may enhance response rates for patients with head and neck squamous cell carcinoma (HNSCC), published in Clinical Cancer Research (published...
A recent study suggests that immunotherapies targeting both PD-L1 and PD-L2 may enhance response rates for patients with head and neck squamous cell carcinoma (HNSCC), published in Clinical Cancer Research (published...
A...
06/15/2017
Journal of Clinical Pathways
Research in Review
Panel Highlights Uses of Genomic Testing for Breast Cancer
06/07/2017
JCP Editors
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...
A...
06/07/2017
Journal of Clinical Pathways
Research in Review
CAR T-Cells May Have Therapeutic Value in Solid Cancers
06/07/2017
JCP Editors
Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...
Chimeric antigen receptor (CAR) T-cells may elicit responses in solid cancers by inducing cancer cell death and the release of tumor antigens that could stimulate T-cell activity, according to research presented at...
...
06/07/2017
Journal of Clinical Pathways
Research in Review
Financial Benefit of NGS Varies by Patient, Disease Type in Community Settings
06/01/2017
JCP Editors
Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...
Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...
...
06/01/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use